May 17–20, 2021 Detroit Michigan. Automation is helping companies in every industry become stronger global competitors. To succeed, you need the right solution providers, the right technology, and the right expertise. Automate 2019 will provide it all and more!
This biennial show held in Detroit, Michigan is North America’s largest showcase of robot, machine vision, motion control and other automation technologies.
Hahn says it is showcasing a “broad spectrum” of automation solutions which can help manufacturers around the world to automate more than ever before.
At the ongoing Automate Show, in Chicago April 8–11, 2019, experts of the Hahn Group are giving insights about industrial automation and robot solutions at booth #7372.
Hahn Automation, Rethink Robotics, and Walther Systemtechnik will be present at the show.
Continue reading “Hahn showcases ‘broad spectrum’ of automation solutions at Automate” »
SpaceFund is a new type of venture capital firm, providing near-term liquidity through security tokens and informed investing in a diversified portfolio of space companies.
Bitcoin advanced to the highest level of 2019, the latest milestone for cryptocurrencies as they claw back from a year that saw three-quarters of their market value wiped out.
The biggest digital coin on Monday rose as much as 1.6 percent to $4,135.60, the top intraday level since Dec. 24, according to weekday trading data compiled by Bloomberg. So-called alternative coins rallied more, with Dash jumping as much as 31 percent and Monero increasing as much as 10 percent.
Bitcoin is close to breaking above an intraday level set on Christmas Eve. That day marked the end of a U.S. stocks selloff, after which the S&P 500 Index started a rally that continued through March and reversed most of the fourth-quarter rout.
Continue reading “Bitcoin Climbs to Highest This Year as Volatility Recedes” »
THIS WEEK, I interviewed Yuval Noah Harari, the author of three best-selling books about the history and future of our species, and Fei-Fei Li, one of the pioneers in the field of artificial intelligence. The event was hosted by the Stanford Center for Ethics and Society, the Stanford Institute for Human-Centered Artificial Intelligence, and the Stanford Humanities Center. A transcript of the event follows, and a video is posted below.
Historian Yuval Noah Harari and computer scientist Fei-Fei Li discuss the promise and perils of the transformative technology with WIRED editor in chief Nicholas Thompson.
Continue reading “Will Artificial Intelligence Enhance or Hack Humanity?” »
It’s basically a lightsaber. Except smaller. And with an invisible blade. And cold to the touch. But other than that, this homebrew cold plasma torch (YouTube, embedded below) is just like the Jedi’s choice in elegant weaponry.
Perhaps we shouldn’t kid [Justin] given how hard he worked on this project – seventeen prototypes before hitting on the version seen in the video below – but he himself notes the underwhelming appearance of the torch without the benefit of long-exposure photography. That doesn’t detract from how cool this build is, pun intended. As [Justin] explains, cold plasma or non-equilibrium plasma is an ionized stream of gas where the electron temperature is much hotter than the temperature of the heavier, more thermally conductive species in the stream. It’s pretty common stuff, seen commercially in everything from mercury vapor lamps to microbial sterilization.
Continue reading “Cold Plasma Torch Produces a Cleansing Flame that Never Consumes” »
As NASA seeks cost-effective access to destinations across the inner solar system, including cislunar space and Mars, it also seeks to shorten the cycle of time to develop and infuse transformative technologies that increase the nation’s capabilities in space, enable NASA’s future missions and support a variety of commercial spaceflight activities.
NASA’s Solar Electric Propulsion (SEP) project is developing critical technologies to extend the length and capabilities of ambitious new science and exploration missions. Alternative propulsion technologies such as SEP may deliver the right mix of cost savings, safety and superior propulsive power to enrich a variety of next-generation journeys to worlds and destinations beyond Earth orbit.
Energized by the electric power from on-board solar arrays, the electrically propelled system will use 10 times less propellant than a comparable, conventional chemical propulsion system, such as those used to power the space shuttles to orbit. Yet that reduced fuel mass will deliver robust power capable of propelling robotic and crewed missions well beyond low-Earth orbit — sending exploration spacecraft to distant destinations or ferrying cargo to and from points of interest, laying the groundwork for new missions or resupplying those already underway. Mission needs for high-power SEP are driving the development of advanced technologies the project is developing and demonstrating including large, light-weight solar arrays, magnetically shielded ion propulsion thrusters, and high-voltage power processing units.
An estimated 30 million Americans are affected by osteoarthritis according to the CDC, and it is predominantly a disease of older age affecting more than 1 in 10 people aged 60+; with the aging population this number is likely to continue to rise steadily.
When cartilage naturally cushioning joints breaks down, osteoarthritis of the knee occurs, without this buffer bones can come into contact with each other causing pain, stiffness, and loss of flexibility.
Medications and physical interventions can ease symptoms of osteoarthritis, but currently there is no sure as it is not possible to regrow cartilage, once progressed to end stages the only option is surgical replacement of the joint. Stem cells were recently used to ease osteoarthritis in a small scale preliminary trial with promising results that will pave the way for more larger studies.
Continue reading “Combating Osteoarthritis With Stem Cells” »
Stem cells are pluripotent cells, having a property of differentiating into various types of cells of human body. Several studies have developed mesenchymal stem cells (MSCs) from various human tissues, peripheral blood and body fluids. These cells are then characterized by cellular and molecular markers to understand their specific phenotypes. Dental pulp stem cells (DPSCs) are having a MSCs phenotype and they are differentiated into neuron, cardiomyocytes, chondrocytes, osteoblasts, liver cells and β cells of islet of pancreas. Thus, DPSCs have shown great potentiality to use in regenerative medicine for treatment of various human diseases including dental related problems. These cells can also be developed into induced pluripotent stem cells by incorporation of pluripotency markers and use for regenerative therapies of various diseases. The DPSCs are derived from various dental tissues such as human exfoliated deciduous teeth, apical papilla, periodontal ligament and dental follicle tissue. This review will overview the information about isolation, cellular and molecular characterization and differentiation of DPSCs into various types of human cells and thus these cells have important applications in regenerative therapies for various diseases. This review will be most useful for postgraduate dental students as well as scientists working in the field of oral pathology and oral medicine.
Keywords: Human dental pulp stem cells, Mesenchymal stem cells, Dentin, Pluripotency, Stem cell therapy, Molecular markers.
Core tip: Human dental pulp stem cells (DPSCs) have shown a potentiality for the treatment of various human diseases including dental related problems. The review will overview the information about DPSCs, their isolation, cellular and molecular characterization, differentiation into various types of cells and their applications in regenerative therapies for various diseases. This review will be most useful for postgraduate dental students as well as the scientists working in the field of oral pathology, oral medicine and regenerative medicine.
Continue reading “Human dental pulp stem cells: Applications in future regenerative medicine” »
